TWN
Sangeeta Shashikant
The findings of the report from the United States International Trade Commission (USITC) relating to COVID-19 diagnostics and therapeutics affirm the insufficiency of existing initiatives such as voluntary licenses, tier-pricing and access schemes of international organizations in facilitating prompt access to these medical products in developing countries.